Schölmerich J - Search Results

1

Schölmerich J. Schölmerich J. Dig Dis. 2016;34(5):461. doi: 10.1159/000445851. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27333056 No abstract available.

2

Trichuris suis ova in inflammatory bowel disease.

Schölmerich J. Schölmerich J. Dig Dis. 2013;31(3-4):391-5. doi: 10.1159/000354708. Epub 2013 Nov 14. Dig Dis. 2013. PMID: 24246995 Review.

3

Trichuris suis ova, lecithin and other fancy molecules.

Schölmerich J. Schölmerich J. Dig Dis. 2014;32 Suppl 1:67-73. doi: 10.1159/000367831. Epub 2014 Dec 17. Dig Dis. 2014. PMID: 25531355 Review.

4

Combined immunosuppression is more dangerous than monotherapy: what is fact and what is fiction?

Schölmerich J. Schölmerich J. Dig Dis. 2012;30(4):404-7. doi: 10.1159/000338140. Epub 2012 Jul 12. Dig Dis. 2012. PMID: 22796806 Review.

5

Evolving concepts in IBD therapy: What should be studied in the future?

Schölmerich J. Schölmerich J. Dig Dis. 2010;28(3):472-7. doi: 10.1159/000320404. Epub 2010 Sep 30. Dig Dis. 2010. PMID: 20926874

6

A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease.

Schölmerich J, Fellermann K, Seibold FW, Rogler G, Langhorst J, Howaldt S, Novacek G, Petersen AM, Bachmann O, Matthes H, Hesselbarth N, Teich N, Wehkamp J, Klaus J, Ott C, Dilger K, Greinwald R, Mueller R; International TRUST-2 Study Group. Schölmerich J, et al. J Crohns Colitis. 2017 Apr 1;11(4):390-399. doi: 10.1093/ecco-jcc/jjw184. J Crohns Colitis. 2017. PMID: 27707789 Free PMC article. Clinical Trial.

7

Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn's Disease.

Jaeger SU, Schaeffeler E, Winter S, Tremmel R, Schölmerich J, Malek N, Stange EF, Schwab M, Wehkamp J. Jaeger SU, et al. Among authors: scholmerich j. Front Pharmacol. 2018 Jul 16;9:764. doi: 10.3389/fphar.2018.00764. eCollection 2018. Front Pharmacol. 2018. PMID: 30061834 Free PMC article.

8

The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations.

Hafner S, Timmer A, Herfarth H, Rogler G, Schölmerich J, Schäffler A, Ehrenstein B, Jilg W, Ott C, Strauch UG, Obermeier F. Hafner S, et al. Among authors: scholmerich j. Eur J Gastroenterol Hepatol. 2008 Jun;20(6):561-6. doi: 10.1097/MEG.0b013e3282f495dd. Eur J Gastroenterol Hepatol. 2008. PMID: 18467916

9

The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.

Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A. Ott C, et al. Among authors: scholmerich j. Eur J Gastroenterol Hepatol. 2008 Sep;20(9):917-23. doi: 10.1097/MEG.0b013e3282f97b33. Eur J Gastroenterol Hepatol. 2008. PMID: 18794607 Free article.

10

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD. Turner D, et al. Among authors: scholmerich j. Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19. Gastroenterology. 2021. PMID: 33359090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

898 results

Search Page